This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Introduction Pharmaceuticalcompanies are investing heavily in digital advertising , and PPC campaign optimization is key to maximizing ROI while staying compliant. Leverage first-party data to refine retargeting strategies while maintaining HIPAA compliance. How do pharma brands ensure compliance in PPC advertising?
Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of third-party cookies, which all marketers must consider. For pharmaceuticalcompanies, this need is even more pressing.
Brands must adhere to HIPAA, FDA, and GDPR guidelines when collecting and using patient data. Why is digital marketing important for pharmaceuticalcompanies? For instance, targeted email campaigns for endocrinologists discussing new advancements in diabetes management will be far more effective than generic drug promotions.
Source: Deloitte Combining these types of health data allows pharmaceuticalcompanies to understand a person’s health and genetic profile better, thereby improving the quality of healthcare products and services. Pharma companies deal with enormous amounts of health data. What Is Health Data Management?
As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. With the increasing digitization of healthcare, pharmaceuticalcompanies are leveraging digital platforms to reach broader audiences more effectively.
Pharmaceuticalcompanies are leveraging AI and data analytics to create hyper-personalized campaigns. Navigating HIPAA regulations while tailoring messages requires careful planning and ethical decision-making. Thats the power of personalization, and its at the heart of modern pharma marketing.
Breaches of HIPAA in the US can result in fines of up to $50,000. One solution that increasing numbers of pharmaceuticalcompanies, healthcare providers, and clinical research organisations are turning to is Cassie by Syrenis, which is a Consent Management Platform (CMP). Grouping and matching for medical data.
The app syncs to a HIPAA-compliant, cloud-based patient management portal to facilitate remote patient monitoring and enables physicians to incorporate the Pulse into their clinical workflow.
Now most pharmaceuticalcompanies that are global in nature will already encounter this from a European compliance standpoint with the GDPR regulation that is more geared toward the US European union. So, this isn’t really something that would technically be super new to pharmaceuticalcompanies that are global.
Cybersecurity challenges As per a Healthcare Information and Management Systems Society (HIMSS) 2022 survey, there is a need for greater awareness on Health Insurance Portability and Accountability Act (HIPAA) and data privacy along with other measures. Pharmaceuticalcompanies that are publicly traded will need to pay attention,” warns Kim.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content